eccogene glp-1 Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule Receptor Agonist ECC5004 for Cardiometabolic Diseases GLP-1 boom causing pharma FOMO

The obesity pandemic continues to pose a global health threat as safe and effective treatments remain elusive

Local low dose Curcumin treatment improves functional recovery and remyelination in a rat model of sciatic nerve crush through Inhibition of oxidative stress

Comes with all necessary items and information

Clinical Limitations and Safety Considerations of Supplement Use While nutritional supplements offer promising benefits for the management of PCOS, several limitations and potential risks must be acknowledged to provide a balanced interpretation of the evidence

If you're on insulin or sulfonylureas, pre-meal cagrilintide dosing can increase hypoglycemia risk